WHO AWaRe

[1][2] The classification is based, in part, on the risk of developing antibiotic resistance and their importance to medicine.

A recent study conducted by Abdelsalam Elshenawy et al. at an English NHS Foundation Trust examined antibiotic prescribing trends during the COVID-19 pandemic, guided by the AWaRe classification.

It shed light on shifting prescription patterns, highlighting the importance of antimicrobial stewardship.

These findings emphasized the imperative for vigilant antimicrobial stewardship to address evolving prescribing trends and combat resistance, thereby safeguarding patient health.

[3][8] Access group antibiotics include amikacin, amoxicillin, amoxicillin/clavulanic acid, ampicillin, benzylpenicillin, cefalexin, chloramphenicol, clindamycin, doxycycline, Metronidazole and nitrofurantoin.

[3] Included in this category are azithromycin, Cefixime, several cephalosporins, ciprofloxacin, clarithromycin, and vancomycin.

[4] The reserve group are generally last line options and used for infections not treatable by other antibiotics, i.e. multi-drug-resistant organisms.